150 related articles for article (PubMed ID: 37156780)
1. Integrative molecular subtypes of acute myeloid leukemia.
Mo Q; Yun S; Sallman DA; Vincelette ND; Peng G; Zhang L; Lancet JE; Padron E
Blood Cancer J; 2023 May; 13(1):71. PubMed ID: 37156780
[No Abstract] [Full Text] [Related]
2. Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia.
Russ AC; Sander S; Lück SC; Lang KM; Bauer M; Rücker FG; Kestler HA; Schlenk RF; Döhner H; Holzmann K; Döhner K; Bullinger L
Haematologica; 2011 Dec; 96(12):1783-91. PubMed ID: 21880628
[TBL] [Abstract][Full Text] [Related]
3. Nucleophosmin mutation in de-novo acute myeloid leukemia.
Rastogi P; Naseem S; Varma N; Varma S
Asia Pac J Clin Oncol; 2016 Mar; 12(1):77-85. PubMed ID: 26669619
[TBL] [Abstract][Full Text] [Related]
4. A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis.
Woolthuis CM; Mulder AB; Verkaik-Schakel RN; Rosati S; Diepstra A; van den Berg E; Schuringa JJ; Vellenga E; Kluin PM; Huls G
Haematologica; 2013 Oct; 98(10):1532-8. PubMed ID: 23716555
[TBL] [Abstract][Full Text] [Related]
5. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition.
Greiner J; Hofmann S; Schmitt M; Götz M; Wiesneth M; Schrezenmeier H; Bunjes D; Döhner H; Bullinger L
Haematologica; 2017 Dec; 102(12):e499-e501. PubMed ID: 28935849
[No Abstract] [Full Text] [Related]
7. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetically normal acute myeloid leukemia.
Quintas-Cardama A
N Engl J Med; 2008 Aug; 359(6):651-2; author reply 652-3. PubMed ID: 18697246
[No Abstract] [Full Text] [Related]
9. Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia.
Shi Y; Xue Y; Wang C; Yu L
Hematology; 2022 Dec; 27(1):609-619. PubMed ID: 35621728
[TBL] [Abstract][Full Text] [Related]
10. NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation.
Raman HS; Shanmugam V; Li J; Steensma DP; Kim AS; Luskin MR
Leuk Lymphoma; 2021 Jul; 62(7):1790-1792. PubMed ID: 33586600
[No Abstract] [Full Text] [Related]
11. Type C mutation of nucleophosmin 1 acute myeloid leukemia: Consequences of intrinsic disorder.
La Manna S; Florio D; Di Natale C; Lagreca E; Sibillano T; Giannini C; Marasco D
Biochim Biophys Acta Gen Subj; 2022 Aug; 1866(8):130173. PubMed ID: 35597503
[TBL] [Abstract][Full Text] [Related]
12. IDH mutations in acute myeloid leukemia.
Rakheja D; Konoplev S; Medeiros LJ; Chen W
Hum Pathol; 2012 Oct; 43(10):1541-51. PubMed ID: 22917530
[TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of IDH2 mutation for minimal residual disease monitoring in patients with acute myeloid leukemia and its comparison with mutations in NPM1 gene.
Jeziskova I; Razga F; Toskova M; Dvorakova D; Timilsina S; Mayer J; Racil Z
Leuk Lymphoma; 2013 Apr; 54(4):867-70. PubMed ID: 22950897
[No Abstract] [Full Text] [Related]
14. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
[TBL] [Abstract][Full Text] [Related]
15. [Mutation of the nucleophosmin gene in acute myeloid leukemia].
Kiyoi H
Rinsho Ketsueki; 2006 Aug; 47(8):710-6. PubMed ID: 16986709
[No Abstract] [Full Text] [Related]
16. Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia.
Hirsch S; Blätte TJ; Grasedieck S; Cocciardi S; Rouhi A; Jongen-Lavrencic M; Paschka P; Krönke J; Gaidzik VI; Döhner H; Schlenk RF; Kuchenbauer F; Döhner K; Dolnik A; Bullinger L
Haematologica; 2017 Dec; 102(12):2039-2047. PubMed ID: 28971903
[TBL] [Abstract][Full Text] [Related]
17. Nucleophosmin (NPM1) gene variants in Egyptian patients with acute myeloid leukemia.
Ibrahim GH
J Egypt Natl Canc Inst; 2012 Jun; 24(2):55. PubMed ID: 23582595
[No Abstract] [Full Text] [Related]
18. Type F mutation of nucleophosmin 1 Acute Myeloid Leukemia: A tale of disorder and aggregation.
La Manna S; Florio D; Di Natale C; Scognamiglio PL; Sibillano T; Netti PA; Giannini C; Marasco D
Int J Biol Macromol; 2021 Oct; 188():207-214. PubMed ID: 34364939
[TBL] [Abstract][Full Text] [Related]
19. A Curious Novel Combination of
Venanzi A; Rossi R; Martino G; Annibali O; Avvisati G; Mameli MG; Sportoletti P; Tiacci E; Falini B; Martelli MP
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573408
[No Abstract] [Full Text] [Related]
20. Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications.
Ma W; Kantarjian H; Zhang X; Jilani I; Sheikholeslami MR; Donahue AC; Ravandi F; Estey E; O'Brien S; Keating M; Giles FJ; Albitar M
Cancer Biomark; 2009; 5(1):51-8. PubMed ID: 19242062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
